Bayer AG (BAYZF)
57.35
+1.18
(+2.09%)
USD |
OTCM |
Aug 25, 16:00
Bayer Net Income (Quarterly) : 266.26M for June 30, 2026
Net Income (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 266.26M |
| March 31, 2026 | 3.237B |
| December 31, 2025 | -4.365B |
| September 30, 2025 | -1.121B |
| June 30, 2025 | -215.36M |
| March 31, 2025 | 1.372B |
| December 31, 2024 | -349.88M |
| September 30, 2024 | -4.607B |
| June 30, 2024 | -27.99M |
| March 31, 2024 | 2.173B |
| December 31, 2023 | 1.443B |
| September 30, 2023 | -4.979B |
| June 30, 2023 | -2.056B |
| March 31, 2023 | 2.341B |
| December 31, 2022 | 621.21M |
| September 30, 2022 | 555.71M |
| June 30, 2022 | -307.57M |
| March 31, 2022 | 3.695B |
| December 31, 2021 | 1.337B |
| September 30, 2021 | 106.09M |
| June 30, 2021 | -2.804B |
| March 31, 2021 | 2.517B |
| December 31, 2020 | 460.19M |
| September 30, 2020 | -9.006B |
| June 30, 2020 | -10.58B |
| Date | Value |
|---|---|
| March 31, 2020 | 1.507B |
| December 31, 2019 | -35.43M |
| September 30, 2019 | 1.110B |
| June 30, 2019 | 359.56M |
| March 31, 2019 | 1.276B |
| December 31, 2018 | -4.521B |
| September 30, 2018 | 3.274B |
| June 30, 2018 | 962.69M |
| March 31, 2018 | 2.392B |
| December 31, 2017 | -80.06M |
| September 30, 2017 | 908.04M |
| June 30, 2017 | 919.98M |
| March 31, 2017 | 1.819B |
| December 31, 2016 | 322.42M |
| September 30, 2016 | 1.068B |
| June 30, 2016 | 1.573B |
| March 31, 2016 | 1.688B |
| December 31, 2015 | 646.86M |
| September 30, 2015 | 1.105B |
| June 30, 2015 | 1.267B |
| March 31, 2015 | 1.456B |
| December 31, 2014 | 272.31M |
| September 30, 2014 | 1.071B |
| June 30, 2014 | 1.260B |
| March 31, 2014 | 1.952B |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Merck KGaA | 574.38M |
| Breakthrough Chemistry, Inc. | -1.083M |
| Cardiac Biotech Solutions, Inc. | -0.1372M |
| Fresenius SE & Co. KGaA | 463.92M |
| Carl Zeiss Meditec AG | -- |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 12.64B |
| Total Expenses (Quarterly) | 12.39B |
| EPS Diluted (Quarterly) | 0.2592 |
| Enterprise Value | 95.52B |
| Gross Profit Margin (Quarterly) | 58.24% |
| Profit Margin (Quarterly) | 2.11% |
| Earnings Yield | -3.57% |
| Operating Earnings Yield | 12.98% |
| Normalized Earnings Yield | 3.445 |